Clever Leaves to Present at Upcoming November and December Investor Conferences
23 November 2021 - 2:30PM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”
or the “Company”), a leading multinational operator and licensed
producer of pharmaceutical-grade cannabinoids, is scheduled to
participate in the following investor conferences in November and
December 2021:
Cowen 4th
Annual Cannabis Conference Date: Monday, November
29th through Wednesday, December 1st Where: Virtual
panel presentation and 1x1 meetings Panel: Tuesday, November 30th
at 11:50 a.m. Eastern time
CannaVest West Institutional Capital
Forum Date: Thursday, December 16th through Friday,
December 17th Where: Moscone Center, San Francisco, CAPanel:
Friday, December 17th at 2:15 p.m. Eastern time Agenda and
Registration: https://cv.thecannabisindustry.org/
For more information about the conferences or to
schedule a 1-on-1 meeting with Clever Leaves management, please
contact your respective conference representative or contact the
Company’s investor relations team at CLVR@gatewayir.com.
About Clever Leaves Holdings
Inc.
Clever Leaves is a multinational cannabis
company with an emphasis on ecologically sustainable, large-scale
cultivation and pharmaceutical-grade cannabinoid processing as the
cornerstones of its global cannabis business. With operations and
investments in the United States, Canada, Colombia, Germany and
Portugal, Clever Leaves has created an effective distribution
network and global footprint, with a foundation built upon capital
efficiency and rapid growth. Clever Leaves aims to be one of the
industry’s leading global cannabis companies recognized for its
principles, people, and performance while fostering a healthier
global community. Clever Leaves has received multiple international
certifications that have enabled it to increase its export and
sales capacity from its Colombian operations, including European
Union Good Manufacturing Practices (EU GMP) Certification, a Good
Manufacturing Practices (GMP) Certification by Colombia National
Food and Drug Surveillance Institute - Invima, and Good
Agricultural and Collecting Practices (GACP) Certification. Clever
Leaves was granted a license in Portugal from Infarmed – the
Portuguese health authority – which allows Clever Leaves to
cultivate, import and export dry flower for medicinal and research
purposes. In addition, the Portuguese operation was also granted
certification of compliance with GACP and IMC-GAP.
Clever Leaves Investor
Inquiries:Cody Slach or Jackie KeshnerGateway Investor
Relations+1-949-574-3860CLVR@gatewayir.com
Clever Leaves Press
Contacts:McKenna MillerKCSA Strategic
Communications+1-347-487-6197mmiller@kcsa.com
Diana SigüenzaStrategic Communications
Director+57-310-236-8830diana.siguenza@cleverleaves.com
Clever Leaves Commercial
Inquiries:Andrew MillerVice President Sales - EMEA, North
America, and
Asia-Pacific+1-416-817-1336andrew.miller@cleverleaves.com
Project Change Lives
Inquiries:PCLInquiries@cleverleaves.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024